Načítá se...

The dawn of hedgehog inhibitors: Vismodegib

Cancer, one of the leading causes of death worldwide is estimated to increase to approximately 13.1 million by 2030. This has amplified the research in oncology towards the exploration of novel targets. Recently there has been lots of interest regarding the hedgehog (Hh) pathway, which plays a signi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sandhiya, Selvarajan, Melvin, George, Kumar, Srinivasamurthy Suresh, Dkhar, Steven Aibor
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications & Media Pvt Ltd 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3643342/
https://ncbi.nlm.nih.gov/pubmed/23662017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.107628
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!